Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.